TNPSC Thervupettagam

Antimicrobial resistance vaccines

July 26 , 2022 853 days 735 0
  • The WHO released the first-ever report on the pipeline of the vaccines currently developing to prevent infections by AMR bacterial pathogens.
  • Resistant-bacterial infections are associated with nearly 4.95 million deaths per year.
  • In that, 1.27 million deaths are directly attributed to AMR.
  • There are already vaccines available against four priority bacterial pathogens:
    • Pneumococcal disease (Streptococcus pneumoniae),
    • Hib (Haemophilus influenzae type b)
    • Tuberculosis (mycobacterium tuberculosis) and
    • Typhoid fever (Salmonella Typhi).
  • Except TB vaccine, the remaining three vaccines are effective.

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories